EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extended versus limited pelvic lymph node dissection and long‐term outcomes in high‐risk prostate cancer before radiotherapy

Georgios Daouacher iD, Jessica Carlsson, Pernilla Sundqvist, Mauritz Waldén

BJUI Compass · 2026-03 · 7 (3)

DOI: 10.1002/bco2.70193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJUI Compass, online erschienen am 22.03.2026. Verfasst von Georgios Daouacher und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Örebro University Örebro Sweden. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Värmland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To compare oncological outcomes after extended pelvic lymph node dissection (PLND) versus limited in patients with high‐risk prostate cancer (PCa) undergoing curative external beam radiation therapy (EBRT). Patients and Methods From 3627 men with PCa at a single centre between 2000 and 2013, 167 with high‐risk, age ≤75, Gleason score 6–10, clinical stage T1–T3, PSA < 100 ng/ml, no distant metastases (M1) and node‐negative at the obturator fossa, underwent PLND before curative EBRT. Of these, 90 received limited, and 77 underwent extended PLND. Mean follow‐up (SD) was 14.9 yr (5.8) for the limited and 12.3 yr (3.3) for the extended PLND. Primary endpoint was biochemical recurrence (BCR), secondary M1, cancer–specific mortality (CSM), overall mortality (OM). HR, KM and Cox regression models adjusted for age and Cambridge prognostic group (CPG) score. RR, RD at 11 yr.

Results

Extended PLND was associated with a significantly lower risk for BCR (HR: 0.51, 95% CI: 0.31–0.86, p = 0.01) (RR: 0.43, 95% CI: 0.26–0.69, p = 0.001 ), lower risk of M1 (HR: 0.22, 95% CI: 0.08–02.65, p = 0.006 ) (RR: 0.26, 95% CI: 0.09–0.73, p = 0.004 ) and lower CSM compared with limited PLND (HR: 0.31, 95% CI: 0.08–0.65 p = 0.035) (RR 0.27, 95% CI: 0.08–0.91, p = 0.028). OM did not differ significantly.

Conclusions

Extended PLND prior to curative ERBT shows reductions in BCR, M1 and CSM long‐term outcomes following extended versus limited PLND. Extended PLND can be considered in cases with high‐risk PCa prior to curative EBRT.

Schlagwörter

Stichwörter der Autor:innen

external beam radiation therapyhigh‐risk prostate cancerpelvic lymph node dissectionprostate cancer: biochemical recurrence

Autor:innen und Institutionen

  • Faculty of Medicine and Health Örebro University Örebro Sweden.
  • Department of Urology Central Hospital of Karlstad Karlstad Sweden.
  • Department of Urology, Faculty of Medicine and Health Örebro University Örebro Sweden.

ORCID-Profile: Georgios Daouacher

Förderung

  • Region Värmland

Zitieren

APA

Daouacher, G., Carlsson, J., Sundqvist, P., & Waldén, M. (2026). Extended versus limited pelvic lymph node dissection and long‐term outcomes in high‐risk prostate cancer before radiotherapy. BJUI Compass, 7(3). https://doi.org/10.1002/bco2.70193

Vancouver

Daouacher G, Carlsson J, Sundqvist P, Waldén M. Extended versus limited pelvic lymph node dissection and long‐term outcomes in high‐risk prostate cancer before radiotherapy. BJUI Compass. 2026;7(3). doi:10.1002/bco2.70193

BibTeX
@article{Daouacher2026,
  author = {Daouacher, Georgios and Carlsson, Jessica and Sundqvist, Pernilla and Waldén, Mauritz},
  title = {Extended versus limited pelvic lymph node dissection and long‐term outcomes in high‐risk prostate cancer before radiotherapy},
  journal = {BJUI Compass},
  year = {2026},
  volume = {7},
  number = {3},
  doi = {10.1002/bco2.70193}
}
Kostenlos starten →